Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding

Journal of Immunology

Volumn 156, Issue 3, 1996, Pages 1055-1061

  Routes, John M ^a,b   Li, Han ^a   Bayley, Stanley T ^c   Ryan, Sharon ^a   Klemm, Dwight J ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PROTEIN P107; PROTEIN P300; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT GAMMA INTERFERON; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS 2; ADENOVIRUS 5; ANTIGEN BINDING; ARTICLE; BINDING SITE; CYTOLYSIS; DELETION MUTANT; EXON; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS INFECTION; VIRUS MUTANT;

EID: 0030032903     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Welsh, R. M. 1986 Regulation of virus infections by natural killer cells A review Natl Immun. Cell Growth Regul. 5.169.
2. Pitkaranta, A., and T. Hovi. 1993 Induction of interferon in human leucocyte cultures by natural pathogenic respiratory viruses. J. Interferon Res. 13:423
3. Welsh, R M. 1986. Natural killer cells and interferon. CRC Crit Rev. Immunol 5:55
4. Bukowski, J. F., and R. M Welsh. 1985. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo J. Immunol. 135:3537.
5. Trinchieri, G., D. Santoli, R Dee, and B. Knowles. 1978. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J. Exp. Med. 147:1299
6. Brutkiewicz, R. R., and R. M. Welsh. 1995. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J. Virol 69:3967.
7. Routes, J M. 1992. Interferon increases class I MHC Ag expression on adenovirus infected human cells without inducing resistance to NK cell killing. J. Immunol. 149:2372
8. Routes, J. M 1993. Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells. J. Immunol 150:4315.
9. Perricaudet, M , G Akusjarvi, A Virtanen, and U. Petterson. 1919. Structure of two spliced mRNAs from the transforming region of human subgroup C adenovirus Nature (Lond ) 281:694
10. Bayley, S. T, and J. S. Mymryk. 1994. Adenovirus E1A proteins and transformation. Intl. J. Oncol. 5 425.
11. Frisch, S. M 1991. Antioncogenic effect of adenovirus E1A in human tumor cells. Proc. Natl. Acad. Sci USA 88:9077.
12. Wang, H -G. H., Y. Rikitake, M. C. Carter, P Yaciuk, S E. Abraham, B. Zerler, and E. Moran. 1993 Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth J. Virol. 67:476.
13. Egan, C., T. N. Jelsma, J. A. Howe, S T. Bayley, B. Ferguson, and P. E. Branton 1988. Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. Mol. Cell Biol 8:3955.
14. Howe, J. A., J. S. Mymryk, C. Egan, P. E. Branton, and S T. Bayley. 1990 Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis Proc. Natl. Acad. Sci. USA 87:5883.
15. Mymryk, J S., and S T Bayley. 1993. Multiple pathways for gene activation in rodent cells by the smaller adenovirus E1A protein and their relevance to growth and transformation J. Gen Virol. 74:2131.
16. Moran, E , T. Grodzicker, R. J. Roberts, M. B Mathews, and B. Zerler. 1986. Lytic and transforming functions of individual products of the adenovirus E1A gene. J Virol. 57:765.
17. Trinchieri, G., M. Matsumoto-Kobayashi, S. C. Clark, J. Seehra, L. London, and B. Perussia. 1984. Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp. Med 160.1147.
18. Ellis, T., R. McKenzie, P. Simms, B. Helfrich, and R. Fisher. 1989 Induction of human lymphokine-activated killer cells by IFN-α and IFN-γ. J. Immunol. 143: 4282.
19. Cook, J. L., D. L. May, A. Lewis, Jr., and T. A. Walker. 1987. Adenovirus E1A gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells. J. Virol. 61:3510.
20. Harlow, E., R. Franza, Jr., and C Schley. 1985. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products J. Virol. 55:533.
21. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
22. Thomas, P. 1978. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci USA 77:5201
23. Moran, B , and B Zerler. 1988. Interactions between cell growth-regulating domains in the products of the adenovirus E1A oncogene. Mol. Cell Biol 8.1756.
24. Ackrill, A. M., G. R. Foster, C D. Laxton, D. M. Flavell, and G. R. Stark. 1991. Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res. 19:4387.
25. Gutch, M., and N. Reich 1991. Repression of the Interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. USA 88:7913.
26. Kalvakolanu, D. V. R., S K. Bandyopadhyay, M. L. Harter, and G. C. Sen. 1991. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. USA 88:7459.
27. Sims, S. S., C. Ying, M. F. Romine, P.-Q. Gao, K. Gottlieb, and A. Deisseroth 1993. A novel interferon-inducible domain, structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol. 13:690.
28. Routes, J. M., and S. Ryan. 1995 Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells. J. Virol. 69:7639.
29. Phelps, W. C., C. L Yee, K. Münger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53.539.
30. Dyson, N , P. Guida, K. Munger, and E Harlow 1992. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins J. Virol. 66:6893.
31. Lillie, J. W , P. M Loewenstein, M. R. Green, and M. Green. 1987. Functional domains of adenovirus type 5 E1a proteins. Cell 50:1091
32. Jelsma, T. N., J. A Howe, J S. Mymryk, C. M. Evelegh, N. F. A. Cunniff, and S. T. Bayley. 1989. Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigen. Virology 171:120
33. Stein, R. W., M. Corrigan, P. Yaciuk, J Whelan, and E. Moran. 1990. Analysis of E1A-mediated growth regulatory functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA-synthesis activity. J. Virol. 64:4421.
34. Rochette-Eagly, C., C. Fromental, and P. Chambon. 1990. General repression of euhanson activity by adenovirus-2 E1A proteins Genes Dev. 5:1200.
35. Eckner, R., M. E Ewen, D. Newsome, M Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston 1994. The molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8 869.
36. Arany, Z., D. Newsome, E Oldread, D. M. Livingston, and R. Eckner. 1995 A family of transcriptional adaptor proteins targeted by the E1A protein. Nature 374.81
37. Lundblad, J. R , R. P Kwok, M. E. Laurance, M L Harter, and R. H. Goodman. 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85.
38. Rikitake, Y , and E. Moran. 1992. DNA-binding properties of the E1A-associated 300-kilodalton protein. Mol Cell Biol. 12-2826.
39. Karre, K , H G. Ljunggren, G. Piontek, and R. Kiessling 1986. Selective rejection of H-2 deficient lymphomas variants suggests alternative immune defense strategy. Nature 319:675.
40. Liao, N -S , M. Bix, M. Zijlstra, R Jaenisch, and D Raulet. 1991 MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253:199.
41. Storkus, W. J., D. N. Howell, R. D. Salter, J. R. Dawson, and P Cresswell. 1987. NK susceptibility varies inversely with target cell class I HLA antigen expression J. Immunol. 138:1657.
42. Daniels, B. F , W. E. Karlhofer, W. E. Seamen, and W. M. Yokoyama. 1994 A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J. Exp. Med. 180:687.
43. + IL-2 activated NK cells. Nature 358.66.
44. Colonna, M., and J. Samaridis. 1995. Cloning of immunoglobulin superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells Science 268:405.
45. Storkus, W J., R. D. Salter, P. Cresswell, and J. R. Dawson. 1992 Peptide-induced modulation of target cell sensitivity to natural killing J Immunol. 143: 3853.
46. Chadwick, B. S., and R. G. Miller. 1992. Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity J. Immunol. 1458:2307.
47. Germain, R. N., and D. H. Margulies. 1993 The biochemistry and cell biology of antigen processing and presentation. Annu. Rev Immunol 11:403.
48. Kast, W. M., R. Offringa, P. J. Peters, A. C. Voordouw, R. H. Meloen, A. J. van der Eb, and C. J. M. Melief. 1989. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59:603
49. Routes, J , D. Bellgrau, W. McGrory, D. Bautista, F Graham, and J. Cook. 1991. Anti-adenovirus type 5 cytotoxic T lymphocytes: immunodominant epitopes are encoded by the E1A gene. J. Virol. 65:1450.
50. Rawle, F. C., B B Knowles, R. P. Ricciardi, V. Brahmacheri, P. Duerkson-Hughes, W. S. M. Wold, and L. Gooding 1991. Specificity of mouse cytotoxic lymphocyte response to adenovirus 5 J. Immunol. 146:3977.
51. Urbanelli, D., Y. Sawada, J. Raskova, N. C. Jones, T. Shenk, and K. Raska, Jr. 1989 C-Terminal domain of the adenovirus E1A oncogene product is required for induction of cytotoxic T lymphocytes and tumor-specific transplantation immunity. Virology 173:607.
52. Cook, J. L., J. R. Hibbs, Jr., and A. M. Lewis, Jr. 1982 DNA virus-transformed hamster cell-host effector cell interactions: level of resistance to cytolysis correlated with tumorigenicity. Int. J. Cancer 30:795.
53. Haddada, H., A. M. Lewis, Jr., J. A. Sogn, J. E. Coligan, J. L. Cook, T. A. Walker, and A. S. Levine. 1986. Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class 1 major histocompatibility antigens expressed on the cells. Proc. Natl. Acad. Sci. USA 83:9684.
54. Raska, K , Jr., and P. H Gallimore. 1982. An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology 123:8.
55. Routes, J. M., and J. L. Cook 1995. E1A gene expression induces susceptibility to killing by NK Cells following immortalization but not adenovirus-infection of human cells. Virology 210:421.
56. Foster, G. R , A. M. Ackrill, R. D. Golding, I. M. Kerr, H. C. Thomas, and G. R. Stark. 1991 Expression of the terminal protein of hepatitis B virus inhibits the cellular response to interferons α and γ and double-stranded RNA. Proc Natl Acad. Sci. USA 88.2888
57. Kanda, K., T. Decker, P. Aman, M Wahlstrom, A. von Gabain, and B. Kallin. 1992. The EBNA2-related resistance towards alpha interferon (IFN-α) in Burkitts' lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3. Mol. Cell. Biol. 12.4930.
58. Upton, C., K. Mossman, and G McFadden. 1992 Encoding of a homolog of the IFN-γ receptor by the myxoma virus Science 258.1369.